Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318049 | SCV000849674 | likely benign | Inborn genetic diseases | 2024-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000862655 | SCV001003189 | likely benign | not provided | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000862655 | SCV001801182 | likely benign | not provided | 2019-03-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003457772 | SCV004177282 | likely benign | Developmental and epileptic encephalopathy, 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003928206 | SCV004756626 | likely benign | SZT2-related disorder | 2023-01-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |